文獻(xiàn)引用
欣博盛生物科技有限公司（NeoBioscience Technology Co, Ltd）是一家致力于生命科學(xué)和生物技術(shù)領(lǐng)域的高科技企業(yè)，公司由在國內(nèi)科研試劑領(lǐng)域有著十幾年從業(yè)經(jīng)驗(yàn)的專業(yè)技術(shù)團(tuán)隊(duì)和企業(yè)管理團(tuán)隊(duì)組建而成，公司自主研發(fā)的ELISA試劑盒品質(zhì)卓越，行業(yè)領(lǐng)先，在國內(nèi)眾多重點(diǎn)實(shí)驗(yàn)室得到廣泛使用，深受廣大科研工作者的好評(píng)。
欣博盛品牌ELISA自推出以來廣受權(quán)威認(rèn)可，得到多篇SCI文獻(xiàn)引用，其中包括Nature，Nature Immunology，PANS，Cell Research等頂刊文獻(xiàn)引用；同時(shí)有數(shù)千篇國內(nèi)核心期刊、博士及碩士論文引用。
欣博盛生物共有3214篇SCI文獻(xiàn)引用。您可以通過篩選功能查看感興趣的文獻(xiàn)。
| 文獻(xiàn) | 指標(biāo) | 種屬 | 樣本類型 |
|---|---|---|---|
| Long J, L. X., Kang Y, et al. Internalization, cytotoxicity, oxidative stress and inflammation of multi-walled carbon nanotubes in human endothelial cells: influence of pre-incubation with bovine serum albumin. RSC Advances 5th March 2018 (2018). Link | IL-6 TNF-α | Human | 常規(guī)樣本 |
| Yu K, M. X., Lin Y, et al. Increased IL-37 concentrations in patients with arterial calcification. Clinica Chimica Acta 20 July 2016 (2016). Link | IL-6 TNF-α | Human | 常規(guī)樣本 |
| Shan Y, H. L., Chen Q, et al. MicroRNA-499 Rs3746444 Polymorphism and Biliary Atresia. Digestive and Liver Disease December 2015 (2015). Link | IL-6 TNF-α | Human | 常規(guī)樣本 |
| Wang Y, Z. X., Xie X, et al. Obesity and metabolic syndrome related macrophage promotes PD-L1 expression in TNBC through IL6/JAK/STAT pathway and can be reversed by telmisartan. . Cancer Biology & Therapy 20 November 2020 (2020). Link | IL-6 TNF-α | Human | 常規(guī)樣本 |
| Chang S, Z. X., Li S, et al. Cytotoxicity, cytokine release and ER stress-autophagy gene expression in endothelial cells and alveolar-endothelial co-culture exposed to pristine and carboxylated multi-walled carbon nanotubes. Ecotoxicology and environmenta Link | IL-6 VCAM-1/CD106 | Human | 常規(guī)樣本 |
| Zhao X, C. S., Long J, et al. The toxicity of multi-walled carbon nanotubes (MWCNTs) to human endothelial cells: The influence of diameters of MWCNTs. Food and Chemical Toxicology 22 February 2019 (2019). Link | IL-6 VCAM-1/CD106 | Human | 常規(guī)樣本 |
| Pan L, X. H., Liao R, et al. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma. Biomedicine & Pharmacotherapy 26 June 2018 (2018). Link | IL-6 VEGF | Human | 常規(guī)樣本 |
| Wang J, C. J., Qiu D, et al. Regulatory role of DEPTOR?mediated cellular autophagy and mitochondrial reactive oxygen species in angiogenesis in multiple myeloma. International Journal of Molecular Medicine 24 December 2020 (2020). Link | IL-6 VEGF | Human | 常規(guī)樣本 |
| J Ye, R Zhu, X He & Y Feng. Association of Plasma IL-6 and Hsp70 with HRV at Different Levels of PAHs Metabolites. PLoS ONE (2014). Link | IL-6 | Human | 常規(guī)樣本 |
| Chen X, W. Y., Jiang Y, Zhou Y, Wang Y, Yao Y, Yi C, Gou L, Yang J. Isoliquiritigenin inhibits the growth of multiple myeloma via blocking IL-6 signaling. Journal of Molecular Medicine (2012 May 31). Link | IL-6 | Human | 常規(guī)樣本 |
